Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting e-cadherin via miR-9

Clinical Cancer Research

Volumn 18, Issue 23, 2012, Pages 6416-6425

  Lu, Mei Hsuan ^a   Huang, Chao Cheng ^b   Pan, Mei Ren ^c   Chen, Hong Hwa ^b   Hung, Wen Chun ^c  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; MATRIX METALLOPROTEINASE; MICRORNA 9; PROSPERO HOMEOBOX 1 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CARCINOGENICITY; CELL ADHESION; CELL INVASION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TRANSCRIPTION REGULATION;

CADHERINS; CELL LINE, TUMOR; COLONIC NEOPLASMS; ENZYME ACTIVATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INTEGRINS; LYMPH NODES; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASES; MICRORNAS; NEOPLASM STAGING; RNA PROCESSING, POST-TRANSCRIPTIONAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84870360174     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-0832     Document Type: Article

References (33)

1. Stone JS, Shang JL, Tomarev S. Expression of Prox1 defines regions of the avian otocyst that give rise to sensory or neural cells. J Comp Neurol 2003;460:487-502. (Pubitemid 36528657)
2. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999;98:769-78. (Pubitemid 29446894)
3. Wigle JT, Chowdhury K, Gruss P, Oliver G. Prox1 function is crucial for mouse lens-fibre elongation. Nat Genet 1999;21:318-22. (Pubitemid 29124943)
4. Sosa-Pineda B, Wigle JT, Oliver G. Hepatocyte migration during liver development requires Prox1. Nat Genet 2000;25:254-5. (Pubitemid 30437306)
5. Nagai H, Li Y, Hatano S, Toshihito O, Yuge M, Ito E, et al. Mutations and aberrant DNA methylation of the PROX1 gene in hematological malignancies. Genes Chromosomes Cancer 2003;38:13-21. (Pubitemid 36994880)
6. Schneider M, Büchler P, Giese N, Giese T, Wilting J, Büchler MW, et al. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread. Int J Oncol 2006;28:883-90.
7. Shimoda M, Takahashi M, Yoshimoto T, Kono T, Ikai I, Kubo H. A homeobox protein, prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma. Clin Cancer Res 2006;12:6005-11. (Pubitemid 44703761)
8. Laerm A, Helmbold P, Goldberg M, Dammann R, Holzhausen HJ, Ballhausen WG. Prospero-related homeobox 1 (PROX1) is frequently inactivated by genomic deletions and epigenetic silencing in carcinomas of the bilary system. J Hepatol 2007;46:89-97. (Pubitemid 44834428)
9. Takahashi M, Yoshimoto T, Shimoda M, Kono T, Koizumi M, Yazumi S, et al. Loss of function of the candidate tumor suppressor PROX1 by RNA mutation in human cancer cells. Neoplasia 2006;8:1003-10. (Pubitemid 44936149)
10. Versmold B, Felsberg J, Mikeska T, Ehrentraut D, Kohler J, Hampl JA, et al. Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer. Int J Cancer 2007;121:547-54. (Pubitemid 46986487)
11. Yoshimoto T, Takahashi M, Nagayama S, Watanabe G, Shimada Y, Sakasi Y, et al. RNA mutations of prox1 detected in human esophageal cancer cells by the shifted termination assay. Biochem Biophys Res Commun 2007;359:258-62. (Pubitemid 46880500)
12. Petrova TV, Nykänen A, Norrmén C, Ivanov KI, Andersson LC, Haglund C, et al. Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell 2008;13:407-19. (Pubitemid 351609440)
13. Dadras SS, Skrzypek A, Nguyen L, Shin JW, Schulz MM, Arbiser J, et al. Prox-1 promotes invasion of kaposiform hemangioendotheliomas. J Invest Dermatol 2008;128:2798-806.
14. Elsir T, Eriksson A, Orrego A, Lindström MS, Nister M. Expression of PROX1 is a common feature of high-grade malignant astrocytic gliomas. J Neuropathol Exp Neurol 2010;69:129-38.
15. Edvardsson K, Ströom A, Jonsson P, Gustafsson JÅ, Williams C. Estrogen receptor β induces anti-inflammatory and antitumorigenic networks in colon cancer cells. Mol Endocrinol 2011;25:969-79.
16. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
17. Pan MR, Chang HC,WuYC, Huang CC, Hung WC. Tubocapsanolide A inhibits transforming growth factor beta-activating kinase 1 to suppress NF-kappaB- induced CCR7. J Biol Chem 2009;284:2746-54.
18. Chang HC, Cho CY, Hung WC. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-mediated promoter methylation. Cancer Res 2006;66:8413-20.
19. Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor gamma ligands in vitro and in vivo. Clin Cancer Res 2008;14:4045-52.
20. Chiang CH, Wang CH, Chang HC, More SV, Li WS, Hung WC. A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling. J Cell Physiol 2010;223:492-9.
21. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010;12:247-56.
22. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008;105:13556-61.
23. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009;125:2737-43.
24. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90.
25. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010;29:4741-51.
26. Hope KJ, Cellot S, Ting SB, MacRae T, Mayotte N, Iscove NN, et al. An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity. Cell Stem Cell 2010;7:101-13.
27. Pedrioli DM, Karpanen T, Dabouras V, Jurisic G, van de Hoek G, Shin JW, et al. miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo. Mol Cell Biol 2010;30:3620-34.
28. Kazenwadel J, Michael MZ, Harvey NL. Prox1 expression is negatively regulated by miR-181 in endothelial cells. Blood 2010;116:2395-401.
29. Laneve P, Gioia U, Andriotto A, Moretti F, Bozzoni I, Caffarelli E. A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation. Nucleic Acid Res 2010;38:6895-905.
30. Schraivogel D, Weinmann L, Beier D, Tabatabai G, Eichner A, Zhu JY, et al. CAMTA1 is a novel tumor suppressor regulated by miR-9/9*in glioblastoma stem cells. EMBO J 2011;30:4309-22.
31. Parise LV, Lee J, Juliano RL. New aspects of integrin signaling in cancer. Semin Cancer Biol 2000;10:407-14. (Pubitemid 32181911)
32. Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 2006;18:516-23. (Pubitemid 44332916)
33. Ramsay AG, Marshall JF, Hart IR. Integrin trafficking and its role in cancer metastasis. Cancer Metastasis Rev 2007;26:567-78. (Pubitemid 350115108)